Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3913189
Max Phase: Preclinical
Molecular Formula: C17H18N2OS
Molecular Weight: 298.41
Molecule Type: Small molecule
Associated Items:
ID: ALA3913189
Max Phase: Preclinical
Molecular Formula: C17H18N2OS
Molecular Weight: 298.41
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cccc2c1N(C(=O)CSc1ccccn1)CCC2
Standard InChI: InChI=1S/C17H18N2OS/c1-13-6-4-7-14-8-5-11-19(17(13)14)16(20)12-21-15-9-2-3-10-18-15/h2-4,6-7,9-10H,5,8,11-12H2,1H3
Standard InChI Key: JEMTWWXNIBTWOA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 298.41 | Molecular Weight (Monoisotopic): 298.1140 | AlogP: 3.46 | #Rotatable Bonds: 3 |
Polar Surface Area: 33.20 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 3.33 | CX LogP: 3.44 | CX LogD: 3.44 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.81 | Np Likeness Score: -1.84 |
1. (2015) Compounds of modulating TRPV3 function, |
Source(1):